Company Directories & Business Directories
eugenio rubio sl
Company Name: Corporate Name:
eugenio rubio sl
Company Title:
Company Description:
Keywords to Search:
Company Address:
pol. ind. pla de la vallonga - calle 5, parcela 85,alicante, alicante 03113 - SPAIN,,Spain
ZIP Code: Postal Code:
Telephone Number:
Fax Number:
Website:
Email:
Number of Employees:
Sales Amount:
Credit History:
Credit Report:
Contact Person:
Remove my name
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example , Blogger Example )
copy to clipboard
Company News:
AI drug designer Genesis Therapeutics forges $200M round with eye on . . . 1440 Chapin Ave Burlingame, CA 4930 Directors Place, Suite 200 San Diego, CA 92121 AI Platform Pipeline People Careers News Contact BD Inquiries: bd@genesistherapeutics ai General Info: info@genesistherapeutics ai Privacy Policy Genesis Therapeutics ©2025
Genesis Therapeutics raises $52M A round for its AI-focused drug . . . 1440 Chapin Ave Burlingame, CA 11568 Sorrento Valley Rd, Ste 8 San Diego, CA 92121 AI Platform Pipeline People Careers News Contact BD Inquiries: bd@genesistherapeutics ai General Info: info@genesistherapeutics ai Privacy Policy Genesis Therapeutics ©2025
a16z’s Bio Eats Health: Supercharging Discovery with Evan Feinberg . . . 1440 Chapin Ave Burlingame, CA 11568 Sorrento Valley Rd, Ste 8 San Diego, CA 92121 AI Platform Pipeline People Careers News Contact BD Inquiries: bd@genesistherapeutics ai General Info: info@genesistherapeutics ai
Genentech-partnered Genesis Therapeutics inks newest AI discovery deal . . . Back November 2024 Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery
In The News Archives - Genesis Therapeutics Venture firm Andreessen Horowitz has co-led a $200 million investment in Genesis Therapeutics, a biotechnology startup that uses artificial intelligence to discover medicines against molecular targets that have thwarted drugmakers